The Precision Peptide Company Inc.
BPC
CNSX
| 04/30/2026 | 01/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -62.15% | 0.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -62.15% | 0.32% | |||
| Cost of Revenue | 121.82% | -70.43% | |||
| Gross Profit | -100.76% | 103.10% | |||
| SG&A Expenses | -67.55% | 37.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -66.77% | 29.49% | |||
| Operating Income | 66.91% | -30.62% | |||
| Income Before Tax | 63.39% | 57.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 63.39% | 57.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 63.39% | 57.84% | |||
| EBIT | 66.91% | -30.62% | |||
| EBITDA | 67.98% | -34.07% | |||
| EPS Basic | 65.10% | 52.69% | |||
| Normalized Basic EPS | 64.78% | -39.47% | |||
| EPS Diluted | 65.10% | 52.69% | |||
| Normalized Diluted EPS | 64.78% | -39.47% | |||
| Average Basic Shares Outstanding | 5.05% | -10.90% | |||
| Average Diluted Shares Outstanding | 5.05% | -10.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||